Incidence of adult T-cell leukemia/lymphoma in nonendemic areas

Current Treatment Options in Oncology
Noriaki Yoshida, Dai Chihara

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is a mature T-cell neoplasm with extremely poor prognosis caused by human T-cell leukemia virus type 1 (HTLV-1). The distribution of HTLV-1 and the incidence of ATLL in endemic areas have been well described, however, little is known about the incidences and the trends of the disease in nonendemic areas. Recently, studies have shown that the HTLV-1 carriers are increasing in nonendemic areas. Also, the incidence of ATLL seems to be significantly increasing in nonendemic areas suggesting that HTLV-1 carriers have emigrated from endemic areas. These epidemiologic studies indicate the necessity of edification of the disease caused by HTLV-1 and establishing appropriate preventive methods against infection in nonendemic areas.

References

May 1, 1991·AIDS Research and Human Retroviruses·M DumasF Denis
Jun 1, 1991·American Journal of Epidemiology·E L MurphyW A Blattner
Mar 1, 1989·Japanese Journal of Cancer Research : Gann·T OkamotoK Shimotohno
Nov 1, 1986·The Journal of Infectious Diseases·W KajiyamaK Okochi
Feb 15, 1989·International Journal of Cancer. Journal International Du Cancer·E L MurphyW A Blattner
Nov 15, 1985·International Journal of Cancer. Journal International Du Cancer·V ManzariM Robert-Guroff
Nov 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·B J PoieszR C Gallo
Mar 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M YoshidaY Hinuma
Jan 22, 1994·Lancet·K Yamaguchi
Sep 1, 1996·British Journal of Haematology·T UchidaT Hotta
May 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y YamadaM Tomonaga
Feb 27, 1999·International Journal of Cancer. Journal International Du Cancer·P H LevineS L Welles
Jan 12, 2000·The Journal of Pathology·K OhshimaM Kikuchi
Jan 25, 2000·The Journal of Emergency Medicine·R F EdlichF M Williams
May 18, 2005·Cancer Letters·Masayuki TawaraShimeru Kamihira
Sep 13, 2005·Oncogene·Fernando A ProiettiEdward L Murphy
Mar 23, 2007·The Lancet Infectious Diseases·Kristien VerdonckEduardo Gotuzzo
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kunihiro TsukasakiUNKNOWN Japan Clinical Oncology Group Study JCOG9801
May 9, 2008·AIDS Research and Human Retroviruses·Caroline M MitchellJane E Hitti
Jul 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie VoseUNKNOWN International T-Cell Lymphoma Project
Jan 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Masao NakagawaMasao Seto
Jun 23, 2009·AIDS Research and Human Retroviruses·Ana TreviñoVincent Soriano
Mar 30, 2010·Blood·Yumi TakasakiKunihiro Tsukasaki
May 8, 2010·Blood·Masako IwanagaUNKNOWN Joint Study on Predisposing Factors of ATL Development investigators
Feb 1, 1997·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M JuilleratY Guigoz
Dec 16, 2011·Journal of Medical Virology·Masahiro SatakeKenji Tadokoro
Jul 19, 2012·Scandinavian Journal of Infectious Diseases·Kerstin MalmSören Andersson
Sep 14, 2012·Frontiers in Microbiology·Masako IwanagaKazunari Yamaguchi
Nov 20, 2013·British Journal of Haematology·Dai ChiharaKeitaro Matsuo
Feb 27, 2014·Nature Communications·Shingo NakahataKazuhiro Morishita
Jun 14, 2014·AIDS Research and Human Retroviruses·Ana TreviñoVincent Soriano
Oct 17, 2014·Cancer Research·Noriaki YoshidaMasao Seto

❮ Previous
Next ❯

Citations

Jun 21, 2016·Expert Opinion on Therapeutic Targets·Alma Chávez-BlancoAlfonso Duenas-Gonzalez
Nov 18, 2017·Annual Review of Immunology·Charles R M Bangham
Oct 27, 2017·The Journal of Dermatology·Toshihisa HamadaKeiji Iwatsuki
Jul 27, 2018·Current Hematologic Malignancy Reports·Adrienne A Phillips, Janine C K Harewood
Feb 13, 2021·Cancer Science·Noriaki YoshidaKoichi Ohshima

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.